VICTORION-1 PREVENT (Follow-up)
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
- Medicine
- Inclisiran
- Population
- ASCVD
- Phase
- III
- Starting year
- 2022